A Randomized Phase II Trial to Simultaneously Evaluate Two Schedules of the Histone Deacetylase Inhibitor Entinostat in Combination With 5-Azacytidine (5AC, NSC 102816) in Elderly Patients With Acute Myeloid Leukemia (AML).
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2017
At a glance
- Drugs Azacitidine (Primary) ; Entinostat (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 28 Mar 2017 Planned End Date changed from 1 Jul 2017 to 1 Feb 2018.
- 28 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Sep 2017.
- 25 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Jul 2017.